Will a hantavirus outbreak offset the regulatory risks weighing on Moderna stock? The path to recovery is far from certain.
Moderna stock climbed after the deadly hantavirus outbreak drew investors' attention to the company's ongoing infectious ...
Shares of Moderna ( MRNA) were up nearly 7% in recent trading, following a 12% jump Friday, after Bloomberg reported the ...
Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm.
Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close ...
The hantavirus outbreak on the MV Hondius poses an ‘extremely low’ overall risk to the public, health officials said ...
Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.
Moderna (MRNA) stock rose 4% on Monday, extending its 12% rally on Friday. What’s behind the move: The biotech is researching ...
Moderna (NASDAQ:MRNA) shares climbed 10% on Thursday as concerns mounted over a hantavirus outbreak connected to a cruise ship.
The biotech company a pre-clinical program with the U.S. Army and a vaccine center at a Korean university.
An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.
March 4 (Reuters) - Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results